These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2147469)
41. [Treatment of hirsutism with spironolactone and with spironolactone plus dexamethasone]. Devoto E; Aravena L; Ríos R Rev Med Chil; 2000 Aug; 128(8):868-75. PubMed ID: 11129548 [TBL] [Abstract][Full Text] [Related]
42. [Hormonal treatments of acne]. Faure M; Drapier-Faure E Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 2):142-7. PubMed ID: 12605145 [No Abstract] [Full Text] [Related]
43. [Hormonal aspects of acne]. Verschoore M Ann Dermatol Venereol; 1987; 114(3):439-54. PubMed ID: 2955737 [No Abstract] [Full Text] [Related]
44. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism]. Suraci C; Costa C; De Pedrini P Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860 [No Abstract] [Full Text] [Related]
45. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi. Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153 [TBL] [Abstract][Full Text] [Related]
46. Hormonal therapy for acne. George R; Clarke S; Thiboutot D Semin Cutan Med Surg; 2008 Sep; 27(3):188-96. PubMed ID: 18786497 [TBL] [Abstract][Full Text] [Related]
47. [Management of virilization with an antiandrogen-containing contraceptive]. Apró G; Sas M Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007 [TBL] [Abstract][Full Text] [Related]
48. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. Plewig G; Cunliffe WJ; Binder N; Höschen K Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212 [TBL] [Abstract][Full Text] [Related]
50. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. Battmann T; Bonfils A; Branche C; Humbert J; Goubet F; Teutsch G; Philibert D J Steroid Biochem Mol Biol; 1994 Jan; 48(1):55-60. PubMed ID: 8136306 [TBL] [Abstract][Full Text] [Related]
56. The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study. Park JH; Bienenfeld A; Orlow SJ; Nagler AR Am J Clin Dermatol; 2018 Jun; 19(3):449-455. PubMed ID: 29556985 [TBL] [Abstract][Full Text] [Related]
57. Low-dose spironolactone in the treatment of female hirsutism. Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814 [TBL] [Abstract][Full Text] [Related]
58. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians. Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Watanabe-Ono A; Suga H; Inoue K; Gonda K; Yoshimura K Aesthetic Plast Surg; 2006; 30(6):689-94. PubMed ID: 17077951 [TBL] [Abstract][Full Text] [Related]
59. Lack of effect of topical spironolactone on sebum excretion. Walton S; Cunliffe WJ; Lookingbill P; Keczkes K Br J Dermatol; 1986 Feb; 114(2):261-4. PubMed ID: 2936373 [No Abstract] [Full Text] [Related]
60. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Unlühizarci K K; Everest H; Bayram F; Keleştimur F Fertil Steril; 2002 Dec; 78(6):1331-3. PubMed ID: 12477537 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]